| scholarly article | Q13442814 |
| P2093 | author name string | Lomas DA | |
| Elliott PR | |||
| Bilton D | |||
| P2860 | cites work | Inhibitory conformation of the reactive loop of alpha 1-antitrypsin | Q27733292 |
| The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A | Q27733963 | ||
| What do dysfunctional serpins tell us about molecular mobility and disease? | Q34058884 | ||
| Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function | Q34255957 | ||
| The Z type variation of human alpha 1-antitrypsin causes a protein folding defect | Q34304294 | ||
| The mechanism of Z alpha 1-antitrypsin accumulation in the liver | Q34440939 | ||
| Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins | Q34515383 | ||
| Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy | Q36279544 | ||
| New insights into the structural basis of alpha 1-antitrypsin deficiency | Q41285548 | ||
| Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A. | Q44020077 | ||
| Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants. | Q49057165 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 670-674 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema | |
| P478 | volume | 18 |
| Q42324381 | 1H, 15N and 13C backbone resonance assignments of the archetypal serpin α1-antitrypsin |
| Q36894255 | Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management |
| Q37056312 | Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. |
| Q36846798 | Alpha-1-antitrypsin deficiency: current concepts |
| Q34428996 | Alpha1-antitrypsin deficiency |
| Q24678705 | Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk |
| Q35788002 | Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology |
| Q24554310 | Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy |
| Q33842205 | Altered native stability is the dominant basis for susceptibility of α1-antitrypsin mutants to polymerization |
| Q38937853 | An ECLIPSE View of Alpha-1 Antitrypsin Deficiency |
| Q37774788 | Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies |
| Q38109518 | Autophagy: a critical regulator of cellular metabolism and homeostasis |
| Q91386795 | Calcium signalling in mammalian cell lines expressing wild type and mutant human α1-Antitrypsin |
| Q36084447 | Cell and gene therapy for genetic diseases: inherited disorders affecting the lung and those mimicking sudden infant death syndrome |
| Q38933451 | Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody |
| Q37118167 | Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency |
| Q24672272 | Cleaved antitrypsin polymers at atomic resolution |
| Q46662744 | Cleaved serpin refolds into the relaxed state via a stressed conformer |
| Q24795113 | Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro |
| Q36045474 | Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment |
| Q74148034 | Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody |
| Q28547169 | Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization |
| Q35973238 | Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases |
| Q36661493 | Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals |
| Q36444154 | Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy. |
| Q57980231 | Identification of a 4-mer Peptide Inhibitor that Effectively Blocks the Polymerization of Pathogenic Z α1-Antitrypsin |
| Q39085645 | Increased ERK signalling promotes inflammatory signalling in primary airway epithelial cells expressing Z α1-antitrypsin |
| Q33880491 | Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy. |
| Q46718946 | Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD. |
| Q38912052 | Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance |
| Q37341652 | Intracellular and extracellular serpins modulate lung disease |
| Q36183894 | Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects |
| Q37466723 | New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy |
| Q51536039 | Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. |
| Q37343918 | Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema |
| Q43180243 | Parker B. Francis lectureship. Antitrypsin deficiency, the serpinopathies, and chronic obstructive pulmonary disease |
| Q37203729 | Polymers and inflammation: disease mechanisms of the serpinopathies |
| Q35755014 | Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo |
| Q42521815 | Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema |
| Q35615846 | Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies |
| Q34450903 | Presence of C1-inhibitor polymers in a subset of patients suffering from hereditary angioedema |
| Q34928474 | Protein misfolding and the serpinopathies |
| Q42790541 | Proteostasis: a new therapeutic paradigm for pulmonary disease |
| Q38111790 | Recent advances in α-1-antitrypsin deficiency-related lung disease |
| Q21284414 | SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase. |
| Q33760369 | Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis |
| Q36388052 | The emerging importance of autophagy in pulmonary diseases |
| Q55011363 | The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. |
| Q41066319 | The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization |
| Q34256009 | The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency |
| Q36378692 | The selective advantage of alpha1-antitrypsin deficiency |
| Q35214289 | Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency |
| Q38092851 | Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency |
| Q35233352 | Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis |
| Q24678727 | alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency |
| Q37474870 | alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies |
| Q35115856 | α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease |
| Q51481224 | α1-Antitrypsin deficiency. |
Search more.